All In MedTech

FDA Clearance Tracker · P040014-S008

THERAPY CARDIAC ABLATION CATHETERS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 17, 2009 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 17, 2009

Approved

Time to decision

286 days

Received Sep 4, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P040014-S008
Device name
THERAPY CARDIAC ABLATION CATHETERS
Applicant location
Irvine, CA
Received
Sep 4, 2008
Decided
Jun 17, 2009
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P040014

Device type

Device class
Class III

Every decision under product code LPB

FDA's approval statement

As written in FDA's record.

APPROVAL FOR SOFTWARE CHANGES IN THE IBI 1500T9 RF GENERATOR WITH SOFTWARE VERSION 1.42.

Source documents

Other decisions for Irvine Biomedical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.